SkyWest (NASDAQ:SKYW – Free Report) had its price target raised by Raymond James from $100.00 to $114.00 in a research note issued to investors on Friday morning, Benzinga reports. The firm currently has an outperform rating on the transportation company’s stock.
SkyWest Price Performance
SkyWest stock opened at $99.24 on Friday. The business’s 50-day simple moving average is $85.31 and its 200 day simple moving average is $80.20. The stock has a market cap of $3.98 billion, a price-to-earnings ratio of 16.96 and a beta of 1.93. SkyWest has a 12-month low of $41.96 and a 12-month high of $103.49. The company has a quick ratio of 0.74, a current ratio of 0.86 and a debt-to-equity ratio of 0.95.
SkyWest (NASDAQ:SKYW – Get Free Report) last released its earnings results on Thursday, October 31st. The transportation company reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.92 by $0.24. SkyWest had a return on equity of 11.02% and a net margin of 7.29%. The firm had revenue of $912.79 million for the quarter, compared to analyst estimates of $896.21 million. During the same quarter in the prior year, the firm posted $0.55 earnings per share. The company’s quarterly revenue was up 19.1% on a year-over-year basis. As a group, research analysts anticipate that SkyWest will post 6.96 earnings per share for the current year.
Institutional Inflows and Outflows
About SkyWest
SkyWest, Inc is the holding company for two scheduled passenger airline operations and an aircraft leasing company. SkyWest’s airline companies provide commercial air service in cities throughout North America with nearly 3,000 daily flights carrying more than 53 million passengers annually. SkyWest Airlines operates through partnerships with United Airlines, Delta Air Lines, American Airlines and Alaska Airlines.
Read More
- Five stocks we like better than SkyWest
- How Investors Can Find the Best Cheap Dividend Stocks
- Intel: Is Now the Time to Be Brave?Â
- Transportation Stocks Investing
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for SkyWest Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SkyWest and related companies with MarketBeat.com's FREE daily email newsletter.